These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3653235)

  • 1. Kinetics of disopyramide in decreased hepatic function.
    Belpaire FM; Bogaert MG
    Eur J Clin Pharmacol; 1987; 32(6):639. PubMed ID: 3653235
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro assessment of stereoselective hepatic metabolism of disopyramide in humans: comparison with in vivo data.
    Le Corre P; Ratanasavanh D; Chevanne F; Gibassier D; Sado P; Le Verge R; Guillouzo A
    Chirality; 1991; 3(5):405-11. PubMed ID: 1756095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of unbound disopyramide enantiomers following oral administration of racemic disopyramide in humans.
    Takahashi H; Ogata H; Shimizu M; Hashimoto K; Masuhara K; Kashiwada K; Someya K
    J Pharm Sci; 1991 Jul; 80(7):709-11. PubMed ID: 1941574
    [No Abstract]   [Full Text] [Related]  

  • 4. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man.
    Hasselström J; Enquist M; Hermansson J; Dahlqvist R
    Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of disopyramide in decreased hepatic function.
    Bonde J; Graudal NA; Pedersen LE; Balsløv S; Angelo HR; Svendsen TL; Kampmann JP
    Eur J Clin Pharmacol; 1986; 31(1):73-7. PubMed ID: 3780831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of disopyramide.
    Bonde J
    Dan Med Bull; 1991 Apr; 38(2):121-33. PubMed ID: 2060320
    [No Abstract]   [Full Text] [Related]  

  • 7. Disopyramide pharmacokinetics and metabolism: effect of inducers.
    Kapil RP; Axelson JE; Mansfield IL; Edwards DJ; McErlane B; Mason MA; Lalka D; Kerr CR
    Br J Clin Pharmacol; 1987 Dec; 24(6):781-91. PubMed ID: 3440098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bioavailability of two slow release preparations of disopyramide.
    Bogaert MG; Belpaire F; De Wilde G; Lefebvre RA
    Eur J Clin Pharmacol; 1991; 40(6):629-30. PubMed ID: 1884747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic interactions between fluconazole and disopyramide in chick embryos.
    Yoshiyama Y; Kanke M
    Biol Pharm Bull; 2005 Jan; 28(1):151-3. PubMed ID: 15635181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transport mechanism of an organic cation, disopyramide, by brush-border membranes. Comparison between renal cortex and small intestine of the rat.
    Takahashi Y; Itoh T; Kobayashi M; Sugawara M; Saitoh H; Iseki K; Miyazaki K; Miyazaki S; Takada M; Kawashima Y
    J Pharm Pharmacol; 1993 May; 45(5):419-24. PubMed ID: 8099959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disopyramide concentrations in human plasma and saliva: comparison of disopyramide concentrations in saliva and plasma unbound concentrations.
    Sagawa K; Mohri K; Shimada S; Shimizu M; Muramatsu J
    Eur J Clin Pharmacol; 1997; 52(1):65-9. PubMed ID: 9143870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
    Kim SY; Benowitz NL
    Drug Saf; 1990; 5(6):393-420. PubMed ID: 2285495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of cimetidine and ranitidine on the pharmacokinetics of disopyramide in man.
    Jou MJ; Huang SC; Kiang FM; Lai MY; Chao PD
    J Pharm Pharmacol; 1997 Nov; 49(11):1072-5. PubMed ID: 9401940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patients.
    Yukawa E; Orio K; Yukawa M; Terao K; Kinoshita H
    J Clin Pharm Ther; 2005 Aug; 30(4):401-5. PubMed ID: 15985054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentially fatal interaction between azithromycin and disopyramide.
    Granowitz EV; Tabor KJ; Kirchhoffer JB
    Pacing Clin Electrophysiol; 2000 Sep; 23(9):1433-5. PubMed ID: 11025903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilsicainide in breast milk from a mother: comparison with disopyramide and propafenone.
    Wakaumi M; Tsuruoka S; Sakamoto K; Shiga T; Fujimura A
    Br J Clin Pharmacol; 2005 Jan; 59(1):120-2. PubMed ID: 15606453
    [No Abstract]   [Full Text] [Related]  

  • 17. [In vitro study, in perfused rabbit heart, of interaction between two anti-arrhythmia agents: amiodarone and disopyramide].
    Akhdim H; Kantelip JP; Stimmesse B; Toubin G; Magnin P
    C R Seances Soc Biol Fil; 1990; 184(5-6):329-34. PubMed ID: 2151805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous absorption of disopyramide, lidocaine and trimecaine.
    Príborský J; Kikuchi K; Takayama K; Nagai T
    Acta Univ Palacki Olomuc Fac Med; 1998; 141():31-3. PubMed ID: 9684478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
    Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
    J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on transport of disopyramide into the intestinal lumen aimed at gastrointestinal dialysis by activated charcoal in rats.
    Arimori K; Nakano M
    J Pharm Pharmacol; 1989 Jul; 41(7):445-9. PubMed ID: 2570848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.